Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 64

Results For "IoT"

1335 News Found

Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran
Clinical Trials | September 11, 2023

Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran

Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension


Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals
Opinion | September 08, 2023

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards


Aptar appoints Sarah Glickman to its Board of Directors
People | September 07, 2023

Aptar appoints Sarah Glickman to its Board of Directors

Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.


Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
Healthcare | September 07, 2023

Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients

This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US


GenNext & SCIEX to co-market HOS workflow for biopharmaceutical research
News | September 06, 2023

GenNext & SCIEX to co-market HOS workflow for biopharmaceutical research

The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics


New tools of diagnosis and therapeutic medicine require holistic approach for desired optimum results, says Dr Jinetdar Singh
Policy | September 06, 2023

New tools of diagnosis and therapeutic medicine require holistic approach for desired optimum results, says Dr Jinetdar Singh

Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”


Insmed announces positive results from Phase III arise study of ARIKAYCE
News | September 06, 2023

Insmed announces positive results from Phase III arise study of ARIKAYCE

Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score


Elekta and IAEA partner to improve access to cancer care in underserved countries
Healthcare | September 01, 2023

Elekta and IAEA partner to improve access to cancer care in underserved countries

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden


Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
People | August 29, 2023

Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation

Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer


IBL Healthcare invests in KNISS Laboratories
Healthcare | August 28, 2023

IBL Healthcare invests in KNISS Laboratories

KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.